Seminars in Cancer Biology is a review journal dedicated to keeping scientists informed of developments in the field of molecular oncology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to cancer biologists, from the underlying genetic and molecular causes of cellular transformation and cancer to the molecular basis of potential therapies. Every issue is edited by a guest editor or editors, an internationally acknowledged expert(s) in the field, and contains approximately eight to twelve authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. 

Topics that will be covered in the next issues are as follows: 
• Role of glycation in different types of cancer 
• Immuno-Oncological Biomarkers 
• Epigenetics: solid tumors and haematological malignancies 
• Current Vision on target enzymes for cancer therapy 
• Translational Cancer Genomics 
• FOXO family in cancer 
• Emerging trends in biomarker discovery: ease of prognosis and prediction in cancer 
• Some chinks in Ras armor: novel cancer therapeutics on the horizon 
• Conference - Cancer Stem Cells: impact on treatment 

Editor
Theresa Vincent
NewYork-Presbyterian Hospital/Weill Cornell Medical Center and Uppsala University, Department of Immunology, New York, United States
Editorial Advisory Board
Mariano Barbacid
Spanish National Cancer Research Centre, Madrid, Spain
Michael M Gottesman
National Cancer Institute, Bethesda, Maryland, United States
Yoshiaki Ito
National University of Singapore, Singapore, Singapore
Karol Sikora
Imperial College London Faculty of Medicine, London, United Kingdom
Robert M Sutherland
Varian Medical Systems Inc, Palo Alto, California, United States
Joyce Taylor-Papadimitriou
Cancer Research UK, London, England, United Kingdom